A qualitative exploration of the downstream impact of a sustained disruption to the methadone supply in Mexico: effects on the mental, financial, and social health of patients with opioid use disorder in Tijuana.  Bórquez A, Goldshear JL, Muño…

Analysis of buprenorphine distribution patterns among pharmacies and hospitals in the USA from 2019 to 2023.  Gikoska M, Florio AK, George A, Piper BJ.  BMJ Open. 2025 Jul 20;15(7):e094454. doi: 10.1136/bmjopen-2024-094454. PMID: 4068523…

Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial.  Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell…

Access to medication treatment for opioid use disorder in fee-for-service medicare.  Taylor EA, Cantor J, Lai J, Agniel D, Simon KI, Stein BD.  Health Aff Sch. 2025 Jun 26;3(7):qxaf130. doi: 10.1093/haschl/qxaf130. PMID: 40747452; PMCID…

Does a take-home dose program result in better patient adherence to methadone? Evidence from Vietnam.  Nong T, Hodgkin D, Diep NB, Capoccia V, Horgan C, Canh HD, Le G.  Harm Reduct J. 2025 Jul 28;22(1):131. doi: 10.1186/s12954-025-01279-…

Schweiz. «Sinnvoll regulieren»: Der Arud-Jahresrückblick 2024 Der Konsum psychoaktiver Substanzen und Aktivitäten mit hohem Suchtpotenzial birgt Risiken für Einzelne und die Gesellschaft. Darum greift der Staat regulierend ein. Aber oft ist die Reg…